This paper is in the following e-collection/theme issue:

Research Letter (86) Cyberpharmacies (48) Cost-Effectiveness and Economics (259) Pharmacology and Pharmaceutics (70) ePrescribing and Innovations in Pharmacies (56)

Published on in Vol 7 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64300, first published .
Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Authors of this article:

Christopher G Youn1 Author Orcid Image ;   Joo Yeon Kim1 Author Orcid Image ;   Vivian B Yang2 Author Orcid Image ;   Gordon H Bae1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Christopher G Youn   1 , MS ;   Joo Yeon Kim   1 , BA ;   Vivian B Yang   2 , MS ;   Gordon H Bae   1 , MD

1 Department of Dermatology, Stanford University School of Dermatology, Redwood City, CA, United States

2 School of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, United States

Corresponding Author:

  • Gordon H Bae, MD
  • Department of Dermatology
  • Stanford University School of Dermatology
  • 450 Broadway, Pavilion C, 2nd Floor
  • Redwood City, CA, 94063
  • United States
  • Phone: 1 650-721-7190
  • Email: gbae@stanford.edu